Help
Subscribe


GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy

 18 December 2017

Advanced search
GastroHep.com - the global online resource for all aspects of gastroenterology, hepatology and endoscopy Profile of Roy Pounder

Home

News  
Journals
Review Articles
Slide Atlas
Video Clips
Online Books
Advanced Digestive Endoscopy
Classical Cases
Conference Diary
PubMed
International GH Links
USA GH Links
National GH Links
National GI Societies
Other Useful Links




Emails on Gastroenterology and Hepatology
the National AIDS Treatment Advocacy Project
Visit the gastroenterology section of the EUMS

News

Late recurrence of Barrett’s esophagus after complete eradication of intestinal metaplasia is rare

A study in the latest issue of Gastroenterology finds that late recurrence of Barrett’s esophagus after complete eradication of intestinal metaplasia is rare.

News image

The goal of treatment for Barrett’s esophagus with dysplasia is complete eradication of intestinal metaplasia.

The long-term durability of complete eradication of intestinal metaplasia has not been well characterized, so the frequency and duration of surveillance are unclear.

Dr Nicholas Shaheen and colleagues from North Carolina, USA report results from a 5-year follow-up analysis of patients with Barrett’s esophagus and dysplasia treated by radiofrequency ablation in the randomized controlled Ablation of Intestinal Metaplasia Containing Dysplasia (AIM) trial.

Participants for the AIM Dysplasia trial were recruited from 19 sites in the United States and had endoscopic evidence of non-nodular dysplastic Barrett’s esophagus ≤8 cm in length.

Subjects were randomly assigned to receive either radiofrequency ablation or a sham endoscopic procedure; patients in the sham group were offered radiofrequency ablation treatment 1 year later, and all patients were followed for 5 years.

92% achieved complete eradication of intestinal metaplasia
Gastroenterology

The researchers collected data on Barrett’s esophagus recurrence and dysplastic Barrett’s esophagus recurrence among patients who achieved complete eradication of intestinal metaplasia.

The team constructed Kaplan-Meier estimates and applied parametric survival analysis to examine proportions of patients without any recurrence and without dysplastic recurrence.

Of 127 patients in the AIM Dysplasia trial, 119 received radiofrequency ablation and met inclusion criteria.

Of those 119, 92% achieved complete eradication of intestinal metaplasia.

Over 401 person-years of follow-up, 32% of patients had recurrence of Barrett’s esophagus or dysplasia, and 17% had dysplasia recurrence.

The incidence rate of Barrett’s esophagus recurrence was 11 per 100 person-years overall; 8 per 100 person-years among patients with baseline low-grade dysplasia, and 14 per 100 person-years among patients with baseline high-grade dysplasia.

The team found that the incidence rate of dysplasia recurrence was 5 per 100 person-years overall, of which 3 per 100 person-years among patients had baseline low-grade dysplasia, and 7 per 100 person-years among patients had baseline high-grade dysplasia.

Neither Barrett’s esophagus nor dysplasia recurred at a constant rate.

There was a greater probability of recurrence in the first year following complete eradication of intestinal metaplasia than in the following 4 years combined.

Dr Sheehan's team concludes, "In this analysis of prospective cohort data from the AIM Dysplasia trial, we found Barrett's esophagus to recur after complete eradication of intestinal metaplasia by radiofrequency ablation in almost one third of patients with baseline dysplastic disease; most recurrences occurred during the first year after complete eradication of intestinal metaplasia."

"However, patients who achieved complete eradication of intestinal metaplasia and remained Barrett’s esophagus free at 1 year after radiofrequency ablation had a low risk of Barrett’s esophagus recurrence."

"Studies are needed to determine when surveillance can be decreased or discontinued; our study did not identify any Barrett’s esophagus or dysplasia recurrence after 4 years of surveillance."

Gastroenterology 2017: 153(3): 681–688.e2
01 September 2017

Go to top of page Email this page Email this page to a colleague

 18 December 2017 
Smoking behaviour predicted the risk of surgery in Crohn's
 18 December 2017 
Colorectal cancer mortality with low-risk adenomas at colonoscopy
 18 December 2017 
Disease activity indices in celiac disease
 15 December 2017 
Inflammatory diet pattern and colorectal cancer risk
 15 December 2017 
Medical cannabinoid legalization policy and vomiting
 15 December 2017 
Molecular classification of Crohn's disease
 14 December 2017 
H. pylori eradication therapies in countries with clarithromycin resistance
 14 December 2017 
Reliability of the IBD index
 14 December 2017 
PPIs and gastric cancer after H.pylori eradication
 13 December 2017 
Management of abnormal liver blood tests
 13 December 2017 
Tryptophan metabolism and IBD activity
 13 December 2017 
Disease severity in NAFLD
 12 December 2017 
Risk factors in undiagnosed cirrhosis
 12 December 2017 
Monitored anesthesia care for outpatient GI endoscopy
 12 December 2017 
High-risk colorectal cancer patients
 06 December 2017 
Reflux-induced chronic cough 
 06 December 2017 
Preventing hepatic encephalopathy-related readmissions
 06 December 2017 
Systemic inflammatory response syndrome in acute-on-chronic liver failure
 05 December 2017 
Childhood obesity into adulthood
 05 December 2017 
CT imaging for acute diverticulitis
 05 December 2017 
Thiopurines and colorectal cancer in IBD
 04 December 2017 
Neoadjuvant chemoradiation for locally advanced rectal cancer
 04 December 2017 
Physical activity and Barrett’s esophagus
 04 December 2017 
Alcohol abstinence and alcoholic hepatitis
 01 December 2017 
Therapeutic drug monitoring in IBD
 01 December 2017 
Insulin therapy and liver cancer among diabetics
 01 December 2017 
Family burden of pediatric Crohn's in the USA
 30 November 2017 
Anastomotic leak after repeat intestinal resection in Crohn’s
 30 November 2017 
Oral capsule– vs colonoscopy-delivered fecal microbiota transplant
 30 November 2017 
Sessile serrated polyps and H. pylori in the USA
 29 November 2017 
Predicting mortality after colectomy for C. diff
 29 November 2017 
Obesity and cancer risk
 28 November 2017 
Surgical treatment delays and colon cancer survival
 28 November 2017 
Celiac disease screening in adult first-degree relatives
 28 November 2017 
Electronic health record alert in primary care in Hep C
 27 November 2017 
Questionnaire fore chronic constipation
 27 November 2017 
Challenges in measuring the affordability of US health care
 27 November 2017 
Early readmission in IBD patients
 24 November 2017 
Osteoporotic fractures in Barrett's esophagus
 24 November 2017 
Center ERCP volume and procedure success
 24 November 2017 
Adipokines and IBD
 23 November 2017 
Pharmacological management of GERD
 23 November 2017 
Incidence of biopsy-verified celiac disease
 23 November 2017 
Distance travelling for rectal cancer outcomes
 22 November 2017 
Challenges of US-trained gastroenterologists when abroad
 22 November 2017 
Surgical treatment delays influence survival in colon cancer
 22 November 2017 
Golimumab in Crohn's disease
 21 November 2017 
Preoperative optimization in IBD patients
 21 November 2017 
Cholangiopathy in critically ill patients
 21 November 2017 
Prepregnancy obesity and maternal mortality
 20 November 2017 
Barriers to hepatitis C treatment
 20 November 2017 
Socioeconomic characteristics in diverticular disease
 20 November 2017 
Endoscopic indices of disease activity for Crohn’s
 17 November 2017 
Predicting microscopic colitis
 17 November 2017 
PPI use and cognitive function in women
 17 November 2017 
Food elimination diets for treatment of adults with eosinophilic esophagitis
 16 November 2017 
NAFLD-hepatocellular carcinoma and survival after orthotopic liver transplant
 16 November 2017 
Prepregnancy obesity and severe maternal morbidity
 16 November 2017 
Celiac disease screening in adult first-degree relatives
 15 November 2017 
Breastfeeding and the risk of IBD

Blackwell Publishing


GastroHep.com is a Blackwell Publishing registered trademark
© 2017 Wiley-Blackwell and GastroHep.com and contributors
Privacy Statement
Disclaimer
About Us